Exclusive

Publication

Byline

US Patent Issued to SYNEDGEN on April 7 for "Methods for treatment or prevention of damage resulting from radiation, trauma or shock" (California, Maryland Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,296, issued on April 7, was assigned to SYNEDGEN INC. (Claremont, Calif.). "Methods for treatment or prevention of damage resulting from ra... Read More


US Patent Issued to Medicrinia on April 7 for "Composition comprising hyaluronic acid and pluronic for preventing or treating articular and cartilage injury" (South Korean Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,297, issued on April 7, was assigned to Medicrinia Co. Ltd. (Seoul, South Korea). "Composition comprising hyaluronic acid and pluronic for ... Read More


US Patent Issued to Azurity Pharmaceuticals on April 7 for "Methods of administering safe colon cleansing compositions" (Massachusetts Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,298, issued on April 7, was assigned to Azurity Pharmaceuticals Inc. (Woburn, Mass.). "Methods of administering safe colon cleansing compos... Read More


US Patent Issued to SYMBIOX on April 7 for "Photosynthetic cellular substances and methods of use thereof" (Chilean Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,299, issued on April 7, was assigned to SYMBIOX INC. (San Diego). "Photosynthetic cellular substances and methods of use thereof" was inven... Read More


US Patent Issued to Beam Therapeutics, UCL BUSINESS on April 7 for "Compositions and methods for treatment of liquid cancers" (British, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,301, issued on April 7, was assigned to Beam Therapeutics Inc. (Cambridge, Mass.) and UCL BUSINESS LTD. (London). "Compositions and methods... Read More


US Patent Issued to Institut Curie, Honing Biosciences, Centre National de la Recherche Scientifique, The University of Zurich on April 7 for "Single domain antibodies and their use in cancer therapies" (French, Swiss Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,302, issued on April 7, was assigned to Institut Curie (Paris), Honing Biosciences (Paris), Centre National de la Recherche Scientifique (Pa... Read More


US Patent Issued to BREXOGEN on April 7 for "Composition comprising exosomes derived from induced pluripotent stem cell-derived mesenchymal stem cell progenitor for prevention or treatment of non-alcoholic steatohepatitis" (South Korean Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,303, issued on April 7, was assigned to BREXOGEN INC. (Seoul, South Korea). "Composition comprising exosomes derived from induced pluripote... Read More


US Patent Issued to GWO XI STEM CELL APPLIED TECHNOLOGY on April 7 for "Method for treating liver cirrhosis by using composition comprising mesenchymal stem cell. extracellular vesicle produced by mesenchymal stem cell, and growth factor" (Taiwanese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,304, issued on April 7, was assigned to GWO XI STEM CELL APPLIED TECHNOLOGY Co. LTD. (Hsinchu County, Taiwan). "Method for treating liver c... Read More


US Patent Issued to Strominnate Therapeutics on April 7 for "Bone marrow microglia progenitor cells and uses thereof" (Swedish Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,305, issued on April 7, was assigned to Strominnate Therapeutics AB (Lund, Sweden). "Bone marrow microglia progenitor cells and uses thereo... Read More


US Patent Issued to The Regents of the University of Colorado, A Body Corporate on April 7 for "Use of ENTPD3 for identification, isolation, and enhancing mature stem cell derived insulin-producing cells" (British, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,306, issued on April 7, was assigned to The Regents of the University of Colorado, A Body Corporate (Denver). "Use of ENTPD3 for identifica... Read More